SGB-017 (ADCI): A novel anticonvulsant with a dual mechanism of action

CNS Drug Reviews

Volumn 5, Issue 4, 1999, Pages 365-378

  Lin, Stephen S ^a   Sun, Lucy R ^a  

^a PFIZER INC   (United States)

Author keywords

Anticonvulsant; NMDA antagonist; Sodium channel blocker

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; DIZOCILPINE; SGB 017; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; DRUG TOLERANCE; EPILEPSY; LEARNING; MEMORY; MOUSE; NONHUMAN; RAT; RECEPTOR BLOCKING; REVIEW;

EID: 0033492089     PISSN: 1080563X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3458.1999.tb00111.x     Document Type: Review

References (34)

1. Ascher P, Nowak L. Electrophysiological studies of NMDA receptors. Trends Neurosci 1987;10(7):284-288.
2. Bertilsson L, Tomson T, Tybring G. Pharmacokinetics: time-dependent changes-autoinduction of carbamazepine epoxidation. J Clin Pharmacol 1986;26:459-462.
3. Catterall W. Molecular mechanisms of inactivation and modulation of sodium channels. Renal Physiol Biochem 1994;17:121-125.
4. Choi D. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988;1:623-534.
5. Coleman MH, Yamaguchi S-I, Rogawski MA. Protection against dendrotoxin-induced clonic seizures in mice by anticonvulsant drugs. Brain Res 1992;575:138-142.
6. Collingridge GL, Bliss TV. Memories of NMDA receptors and LTP. Trends Neurosci 1995;18(2):54-56.
7. Collingridge GL, Bliss TVP. NMDA rcceptors-their role in long-term potentiation. Trends Neurosci 1987;10(7):288-293.
8. Gallager D, Thurkauf A, Rajachandran L, et al. Preclinical evaluation of the side effect profile of enantiomers of the anticonvulsant ADCI. Focus on epilepsy II. Antiepileptic Drugs in the 1990's: Current and Investigational Therapies. 1993.
9. Goldberg M, Choi D. Combined oxygen and glucose deprivation in cortical cell culture: Calcium-dependent and calcium-independent mechanisms of neuronal injury. J Neurosci 1993;13:3510-3524.
10. Gonsalves SF, Gallager DW. Time course for development of anticonvulsant tolerance and GABAergic subsensitivity after chronic diazepam. Brain Res 1987;405:94-99.
11. Grant KA, Colombo G, Grant J, Rogawski MA. Dizocilpine-like discriminative stimulus effects of low affinity uncompetitive NMDA antagonists. Neuropharmacology 1996;35(12):1709-1719.
12. Grant KA, Snell LD, Rogawski MA, Thurkauf A, Tabakoff B. Comparison of the effects of the uncompetitive N-methyl-D-aspartate antagonist (±)-(5-aminocarbonyl-10,11-dihydro-5H-dibenzol[a,d]cyclohepten-5,10-imine (ADCI) with its structural analogs dizocilpine (MK-801) and carbamazepine on ethanol withdrawal seizures. J Pharmacol Exp Therap 1992;260(3): 1017-1022.
13. Jones SM, Rogawski MA. The anticonvulsant (±)-(5-aminocarbonyl-10,11-dihydro-5H-dibenzol[a,d]cyclohepten-5,10-imine [ADCI]) selectively blocks NMDA-activated current in cultured rat hippocampal neurones: kinetic analysis and comparison with dizocilpine. Mol Neuropharmacol 1992;2(4):303-310.
14. Koek W, Woods JH, Winger GD. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J Pharmacol Exp Therap 1988;245:969-974.
15. Loscher W, Schwarz WS. Development of tolerance to the anticonvulsant effect of diazepam in amygdala-kindled rats. Exp Neurol 1985;90:373-384.
16. + channels. J Gen Physiol 1988;92:549-567.
17. Morris RGM, Anderson E, Lynch GS, Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 1986;319:774-776.
18. Morselli PL. Carbamazepine. Absorption, distribution and excretion. In: Levy R, Mattson R, Meldrum B, Penry JK, Dreifuss FE. Antiepileptic drugs. New York: Raven Press, 1989:473-490.
19. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science 1992;258:597-603.
20. Olney JW, Labruyere J. Price MT. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 1989;244:1360-1362.
21. Pleasure SJ, Page C, Lee VM-Y. Pure, postmitotic, polarized; human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci 1992;12(5):1802-1815.
22. Rajachandran L, Kastello AD, Cassella JV, et al. ADCI, a novel anticonvulsant, does not impair avoidance or spatial learning in the rat. Soc Neurosci Abstr 1993;19:
23. Rogawski MA, Dung QL, Uyakul D-C, et al. Anticonvulsant efficacy of ADCI (5-aminocarbonyl-10,11-dihydro-5H-dibenzol[a,d]cyclohepten-5,10-imine) after acute and chronic dosing in mice. Epilepsia 1995;36(6):566-571.
24. Rogawski MA, Yamaguchi S-I, Jones SM, Rice KC, Thurkauf A, Monn JA. Anticonvulsant activity of the low-affinity uncompetitive N-methyl-D-aspartate antagonist (±)-5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (ADCI): comparison with the structural analogs dizocilpine (MK-801) and carbamazepine. J Pharmacol Exp Therap 1991;259(1):30-36.
25. Ruben P, Starkus J, Rayner M. Steady-state availability of sodium channels. Interactions between activation and slow inactivation. Biophys J 1992;61:941-955.
26. Seeburg PH. The molecular biology of mammalian glutamate receptor channels. Trends Neurosci 1993;16:359-364.
27. Seidleck BK, Thurkauf A, Witkin JM. Evaluation of ADCI against convulsant and locomotor stimulant effects of cocaine: comparison with the structural analogs dizocilpine and carbamazepine. Pharmacol Biochem Behav 1994;47(4):839-844.
28. Sun L, Lin SS. The anticonvulsant SGB-017 (ADCI) blocks voltage-gated sodium channels in rat and human neurons: comparison with carbamazepine. Epilepsia 2000, in press.
29. Swinyard E, Woodhead J, White H, Franklin M. General principles: Experimental selection, quantification, and evaluation of anticonvulsants. In: Levy R, Mattson R, Meldrum B, Penry J, Dreifuss F. Antiepileptic drugs. New York: Raven Press, 1989:85-102.
30. Taylor CP, Narasimhan LS. Sodium Channels and Therapy of Central Nervous System Diseases. Adv Pharmacol 1997;39:47-98.
31. White G. The broad spectrum anticonvulsant ADCI blocks TTX sensitive voltage-activated Na channel currents in NE1-115 mouse neuoblastoma cells. Soc Neurosci Abstr 1994;20:1239.
32. Willets J, Balster RL, Leander JD. The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol Sci 1990; 11:423-428.
33. + channels in rat hippocampal neurons. Pflügers Arch 1995;430:437-446.
34. Yamaguchi S-I, and Rogawski MA. Effects of anticonvulsant drugs on 4-aminopyridine-induced seizures in mice. Epilepsy Res 1992;11:9-16.